Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camila Mosci

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2015
Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurementsRyogo Minamimoto, Mehran Jamali, Amir Barkhodari, et al.
Radiology|January 20, 2016
Characterization of Physiologic (18)F FSPG Uptake in Healthy VolunteersCamila Mosci, Meena Kumar, Kamilla Smolarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2015
Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT ImagingRyogo Minamimoto, Camila Mosci, Mehran Jamali, et al.
Radiologia Brasileira|September 13, 2017
Influence of bladder fullness on the detection of urinary tract obstruction by dynamic renal scintigraphyNathalia Novaes Cosenza, Fábio Lau, Mariana Cunha Lopes Lima, et al.
Radiology|May 13, 2015
Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CTAndrei Iagaru, Camila Mosci, Erik Mittra, et al.
Clinical Nuclear Medicine|August 21, 2014
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT aloneSrinath C Sampath, Srihari C Sampath, Camila Mosci, et al.
Nuclear Medicine Communications|August 4, 2021
Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myelomaMaria Emilia Seren Takahashi, Camila Mosci, Gislaine O Duarte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2015
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate CancerRyogo Minamimoto, Andreas Loening, Mehran Jamali, et al.
Nuclear Medicine Communications|February 15, 2020
Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myelomaMaria E S Takahashi, Camila Mosci, Edna M Souza, et al.
Oncotarget|April 19, 2017
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancerAna E Brito, Allan Santos, André Deeke Sasse, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2015
Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurementsRyogo Minamimoto, Mehran Jamali, Amir Barkhodari, et al.
Radiology|January 20, 2016
Characterization of Physiologic (18)F FSPG Uptake in Healthy VolunteersCamila Mosci, Meena Kumar, Kamilla Smolarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2015
Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT ImagingRyogo Minamimoto, Camila Mosci, Mehran Jamali, et al.
Radiologia Brasileira|September 13, 2017
Influence of bladder fullness on the detection of urinary tract obstruction by dynamic renal scintigraphyNathalia Novaes Cosenza, Fábio Lau, Mariana Cunha Lopes Lima, et al.
Radiology|May 13, 2015
Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CTAndrei Iagaru, Camila Mosci, Erik Mittra, et al.
Clinical Nuclear Medicine|August 21, 2014
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT aloneSrinath C Sampath, Srihari C Sampath, Camila Mosci, et al.
Nuclear Medicine Communications|August 4, 2021
Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myelomaMaria Emilia Seren Takahashi, Camila Mosci, Gislaine O Duarte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2015
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate CancerRyogo Minamimoto, Andreas Loening, Mehran Jamali, et al.
Nuclear Medicine Communications|February 15, 2020
Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myelomaMaria E S Takahashi, Camila Mosci, Edna M Souza, et al.
Oncotarget|April 19, 2017
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancerAna E Brito, Allan Santos, André Deeke Sasse, et al.
Pageof 3